NARS ALL DAY LUMINOUS FOUNDATION SIBERIA- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION MONT BLANC- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION DEAUVILLE- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION SWEDEN- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION FIJI- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION PUNJAB- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION SANTA FE- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION BARCELONA- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION LAPONIE- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION VALLAURIS- octinoxate and titanium dioxide powder
NARS COSMETICS

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

NARS ALL DAY LUMINOUS FOUNDATION

Drug Facts

Active ingredients

Octinoxate 4.9%

Titanium Dioxide 8.3%

Purpose

Sunscreen

Uses

helps prevent sunburn
if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

apply liberally 15 minutes before sun exposure
use a water resistant sunscreen if swimming or sweating
reapply at least every 2 hours
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats, and sunglasses
children under 6 months: Ask a doctor

Inactive ingredients

BORON NITRIDE • SYNTHETIC FLUORPHLOGOPITE • NYLON-12 • LAUROYL LYSINE • DIMETHICONE • JOJOBA ESTERS • SILICA • VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER • TRIETHYLHEXANOIN • DIPHENYL DIMETHICONE/VINYL DIPHENYL DIMETHICONE/SILSESQUIOXANE CROSSPOLYMER • DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER • CELLULOSE • ALUMINUM HYDROXIDE • CAPRYLIC/CAPRIC TRIGLYCERIDE • ALUMINUM DISTEARATE • SORBITAN SESQUIISOSTEARATE • CHLORPHENESIN • MAGNESIUM STEARATE • CRITHMUM MARITIMUM EXTRACT • ASCORBYL GLUCOSIDE • TOCOPHEROL • RETINYL PALMITATE • TOCOPHERYL ACETATE • ASCORBIC ACID • GLYCINE • SEA WATER • WATER • SERINE • GLUTAMIC ACID • ASPARTIC ACID • BHT • BARIUM SULFATE • ALANINE • LYSINE • ARGININE • TYROSINE • PHENYLALANINE • VALINE • THREONINE • PROLINE • ISOLEUCINE • HISTIDINE • LEUCINE • ALGAE EXTRACT • PHENOXYETHANOL • ALUMINA • POTASSIUM SORBATE • CITRIC ACID • [+/- (MAY CONTAIN): MICA • TITANIUM DIOXIDE • IRON OXIDES • BISMUTH OXYCHLORIDE] •

Other information

protect this product in this container from excessive heat and direct sun

Questions or comments?

Principal Display Panel - 12 g Tray Carton - Vallauris

NARS ALL DAY LUMINOUS FOUNDATION SIBERIA
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:13734-129
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg in 12 g

Ingredient Name	Strength
Inactive Ingredients
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM WHOLE (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13734-129-30	1 in 1 CARTON	10/01/2014	07/01/2023
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH NOT FINAL	part352	10/01/2014	07/01/2023

NARS ALL DAY LUMINOUS FOUNDATION MONT BLANC
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:13734-130
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg in 12 g

Ingredient Name	Strength
Inactive Ingredients
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM WHOLE (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13734-130-30	1 in 1 CARTON	10/01/2014	07/01/2023
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH NOT FINAL	part352	10/01/2014	07/01/2023

NARS ALL DAY LUMINOUS FOUNDATION DEAUVILLE
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:13734-131
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg in 12 g

Ingredient Name	Strength
Inactive Ingredients
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM WHOLE (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13734-131-30	1 in 1 CARTON	10/01/2014	07/01/2023
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH NOT FINAL	part352	10/01/2014	07/01/2023

NARS ALL DAY LUMINOUS FOUNDATION SWEDEN
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:13734-132
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg in 12 g

Ingredient Name	Strength
Inactive Ingredients
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM WHOLE (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13734-132-30	1 in 1 CARTON	10/01/2014	07/01/2023
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH NOT FINAL	part352	10/01/2014	07/01/2023

NARS ALL DAY LUMINOUS FOUNDATION FIJI
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:13734-133
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg in 12 g

Ingredient Name	Strength
Inactive Ingredients
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM WHOLE (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13734-133-30	1 in 1 CARTON	10/01/2014	07/01/2023
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH NOT FINAL	part352	10/01/2014	07/01/2023

NARS ALL DAY LUMINOUS FOUNDATION PUNJAB
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:13734-134
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg in 12 g

Ingredient Name	Strength
Inactive Ingredients
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM WHOLE (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13734-134-30	1 in 1 CARTON	10/01/2014	07/01/2023
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH NOT FINAL	part352	10/01/2014	07/01/2023

NARS ALL DAY LUMINOUS FOUNDATION SANTA FE
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:13734-135
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg in 12 g

Ingredient Name	Strength
Inactive Ingredients
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM WHOLE (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13734-135-30	1 in 1 CARTON	10/01/2014	07/01/2023
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH NOT FINAL	part352	10/01/2014	07/01/2023

NARS ALL DAY LUMINOUS FOUNDATION BARCELONA
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:13734-136
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg in 12 g

Ingredient Name	Strength
Inactive Ingredients
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM WHOLE (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13734-136-30	1 in 1 CARTON	10/01/2014	07/01/2023
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH NOT FINAL	part352	10/01/2014	07/01/2023

NARS ALL DAY LUMINOUS FOUNDATION LAPONIE
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:13734-137
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg in 12 g

Ingredient Name	Strength
Inactive Ingredients
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM WHOLE (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13734-137-30	1 in 1 CARTON	10/01/2014	07/01/2023
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH NOT FINAL	part352	10/01/2014	07/01/2023

NARS ALL DAY LUMINOUS FOUNDATION VALLAURIS
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:13734-138
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg in 12 g

Ingredient Name	Strength
Inactive Ingredients
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM WHOLE (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13734-138-30	1 in 1 CARTON	10/01/2014	07/01/2023
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH NOT FINAL	part352	10/01/2014	07/01/2023

Labeler - NARS COSMETICS (837363571)

Revised: 9/2023

Document Id: c20134f6-d5bf-44a5-84d5-b7b8024934d0

Set id: e9a6280a-ad94-4209-8d12-40af3d5681b2

Version: 3

Effective Time: 20230908

NARS COSMETICS